September 30, 2014

Q&A: Kazerooni sanguine as Medicare mulls lung cancer screening

More than 60 medical organizations and patient advocacy groups are now pleading with Medicare to cover low dose computed tomography (LDCT) screening for beneficiaries at high risk for lung cancer. Decision day comes in November. Will CMS do the right thing in the eyes of those in favor of screening?